Low-dose CT lung cancer (LDCT) screening is linked to a 16% reduction in lung cancer mortality, stated research presented by Professor John Field and the United Kingdom Cancer Screening Trial (UKLS) Team today at the IASLC 2021 World Conference on Lung Cancer. The research will be published in the Lancet Regional Health-Europe.
Previous studies, such as the National Lung Cancer Screening Trial and The NELSON LDCT screening trial, provided evidence of a statistically significant reduction ...
Low-dose CT lung cancer (LDCT) screening is linked to a 16% reduction in lung cancer mortality, stated research presented by Professor John Field and the United Kingdom Cancer Screening Trial (UKLS) Team today at the IASLC 2021 World Conference on Lung Cancer. The research will be published in the Lancet Regional Health-Europe.
Previous studies, such as the National Lung Cancer Screening Trial and The NELSON LDCT screening trial, provided evidence of a statistically significant reduction ...